Synerga.Fund S.A. engages in the stem cell therapy business for multiple sclerosis in Poland. It focuses on the implementation of medical project in the field of biotechnology and advanced cell therapies. The company was founded in 2010 and is based in Kraków, Poland.
Research context
SNG appears in PyInvesting’s Warsaw Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- PLN
- Sector
- Technology
- Industry
- Software - Application
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
No comments yet
Start a focused discussion about SNG.WAR.